Phase 3 Study of Human TH-SC01 Cell Injection for Treating Perianal Fistulas in Patients With Crohn's Disease

Abroad (travel likely)RecruitingPHASE3

Conditions

Crohn's Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Jiangsu Topcel-KH Pharmaceutical Co., Ltd., Nanjing, Jiangsu, China
Contact: Study coordinator (Jueyu Xia, Master) · xiajueyu@topcelbio.com · 025-52700103
Contact: Principal Investigator (Zhaoshen Li, Ph.D.)
Contact: Principal Investigator (Donglin Ren, Ph.D.)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease

Crohn's Disease · Inflammatory Bowel Diseases

Abroad (travel likely)RecruitingPHASE3

New York, United States

Real-World Study of IL-23 Inhibitors in Active Crohn's Disease

Crohn's Disease

Abroad (travel likely)Recruiting

Guangzhou, China

Ultrasound-Guided Versus Standard Margin Selection in Ileocecal Resection of Terminal Ileal CD

Crohn's Disease (CD)

Abroad (travel likely)Recruiting

Cleveland, United States

Exclusive Enteral Nutrition Therapy for Active and Complicated Crohn's Disease

Crohn's Disease

Abroad (travel likely)Recruiting

Guangzhou, China